This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Elsevier Group | |
|---|---|
| Name | Elsevier Group |
| Type | Private |
| Industry | Publishing |
| Founded | 1880 |
| Headquarters | Amsterdam, Netherlands |
| Products | Scientific journals, databases, books, analytics |
Elsevier Group is a Dutch publishing conglomerate specializing in scientific, technical, and medical publications, databases, and analytics. Founded in the late 19th century, it became a major provider of scholarly journals, books, and research tools that intersect with institutions such as University of Oxford, Harvard University, Stanford University, Max Planck Society, and Chinese Academy of Sciences. Its operations touch stakeholders including research funders like the Wellcome Trust, policy bodies like the European Commission, and consortia such as Project DEAL and Consortium of European Research Libraries.
The company originated in the 1880s amid the growth of learned societies such as the Royal Society and the French Academy of Sciences, expanding through acquisitions of imprints and titles linked to publishers like Academic Press and Pergamon Press. In the 20th century it navigated the upheavals surrounding institutions including the University of Cambridge and publishing trends influenced by events like the Digital Revolution and developments at Bell Labs. Strategic interactions involved partners and rivals such as Springer Nature, Wiley-Blackwell, Taylor & Francis, and mergers guided by executives with connections to corporate actors including RELX Group and financial institutions like Blackstone Group.
The group operates as a division within a larger listed company historically associated with RELX plc, reporting through corporate governance frameworks involving boards with ties to organizations such as London Stock Exchange Group, European Central Bank forums, and audit committees that engage firms like Deloitte and PricewaterhouseCoopers. Its ownership and governance arrangements have been scrutinized by regulatory authorities including agencies comparable to the European Commission Competition Directorate-General and national competition authorities in countries like United Kingdom and Netherlands.
Publishing activities span flagship journals, monographs, reference works, and digital platforms that compete with services from entities like PubMed Central, Scopus, Web of Science, Google Scholar, and ResearchGate. Portfolio components include titles historically associated with academic publishers such as Lancet-class periodicals and specialty journals paralleling offerings from Nature Publishing Group and Cell Press. Products integrate indexing, abstracting, citation metrics, and workflow tools similar to services produced by Clarivate Analytics and analytics used by institutions including Massachusetts Institute of Technology and Johns Hopkins University.
The company’s approach to open access evolved amid negotiations with initiatives such as Plan S, the Wellcome Trust, and national consortia like Project DEAL and CRKN. Licensing frameworks have referenced Creative Commons models exemplified by Creative Commons Attribution (CC BY), transformative agreement structures negotiated with consortia including Figure Sourced Agreements, and embargo policies discussed in forums like SPARC and OpenAIRE. Debates involved funders and repositories such as NIH and European Research Council concerning mandates and compliance monitoring.
The publisher has faced criticism over pricing and access practices from universities and organizations including University of California, Dutch Research Council (NWO), and advocacy groups like Right to Research Coalition and Open Access Scholarly Publishers Association. High-profile disputes referenced negotiations with consortia such as Projekt DEAL and public campaigns by figures associated with Aaron Swartz-related advocacy and revelations discussed in venues like Science and Nature. Additional controversies touched on peer review and retraction debates involving journals that intersected with investigations by entities like Retraction Watch and committees akin to COPE.
Financial metrics placed the publisher among dominant players competing with RELX Group peers and rivals such as Springer Nature and Wiley. Revenue and margin patterns attracted attention from investors and analysts at institutions like Goldman Sachs, Morgan Stanley, and rating agencies similar to Moody's Investors Service. Market share dynamics were discussed in relation to subscription models used by university libraries at University of Michigan, University of Toronto, and consortia including Jisc.
R&D efforts emphasize digital platforms, text and data mining services comparable to work by Microsoft Research, IBM Research, and collaborations with academic centers such as Imperial College London, ETH Zurich, and Karolinska Institute. Initiatives include development of semantic tools, machine-learning applications for literature discovery akin to projects at Allen Institute for AI, and partnerships with infrastructure projects like ORCID and CrossRef to improve metadata and persistent identifier systems.